Developing new methods to create important sugar compounds for medicine
Strategic Molecular Activations for the Selective Synthesis of 2-Deoxy-Beta-Glycosides, and for the Synthesis of Novel Donor-Acceptor Stenhouse Adducts
This study is working on making it easier and more reliable to create important sugar compounds that play a big role in our bodies, which could help us learn more about how these sugars work and how they might be used in medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10767298 on NIH RePORTER |
What this research studies
This research focuses on improving the synthesis of 2-deoxy-β-glycosides, which are important sugar compounds in biological systems. By using innovative chemical techniques, the project aims to create more effective and predictable methods for glycosylation reactions. This could enhance our understanding of how sugars function in biological chemistry and their potential applications in medicine. The approach involves using specialized catalysts to activate both the sugar donors and acceptors, making the synthesis process more efficient and accessible.
Who could benefit from this research
Good fit: Patients with conditions that could benefit from advancements in carbohydrate-based therapies or treatments would be ideal candidates.
Not a fit: Patients who do not have conditions related to carbohydrate metabolism or who are not involved in experimental treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and therapies that utilize sugar compounds in medicine.
How similar studies have performed: While glycosylation methods have been explored, this specific approach using hydrogen-bond-donor catalysts is relatively novel and has not been widely tested.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Picazo, Elias — University of Southern California
- Study coordinator: Picazo, Elias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.